Global Chronic Cough Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Chronic Cough Industry Expected To Reach By 2029, Starting From 2025 Levels?

The chronic cough market has experienced robust expansion in recent years. Projections indicate it will expand from $8.22 billion in 2024 to reach $8.87 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.0%. This historical growth is linked to factors such as the prevalence of underlying respiratory conditions, environmental factors and air pollution, smoking and tobacco use, respiratory infections, and allergies and environmental sensitivities.

The chronic cough market size is forecast to undergo significant expansion in the upcoming years. It is predicted to attain a value of $12.83 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is fueled by the introduction of new therapies targeting specific pathways, a deeper insight into reflux-related cough, international endeavors in smoking cessation, and regulatory frameworks for environmental and occupational health. Prominent trends for the forecast period encompass progress in diagnostic technologies, methodologies focused on patients, therapeutic innovations in neurogenic cough, remote healthcare for chronic cough management, and studies on central sensitization.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

What Are The Main Drivers Boosting The Chronic Cough Industry’s Expansion?

The increasing occurrence of cough is projected to fuel expansion within the chronic cough market in the future. A cough is a reflexive action where air is expelled forcefully from the lungs, typically in response to irritation, mucus, or foreign particles, to clear the airways. A cough is classified as chronic if it persists for a minimum of eight weeks. Consequently, an uptick in cough incidence leads to a corresponding increase in chronic cough cases. For example, data from March 2022, provided by Florida Health, a US-based Department of Healthcare, revealed that in the US, a total of 80 patients were identified in 2021, with incidences reported as 41.0 and 1.4 per 100,000 years, respectively. Additionally, 28 pertussis cases were documented in 2023 across 13 countries. Moreover, in March 2022, the Statens Serum Institut, a Denmark-based department of disease surveillance, reported a 41% surge in pertussis cases from November 2022 to April 2023, when contrasted with the period of November 2021–April 2022 in Denmark. Thus, the escalating prevalence of cough is a key factor propelling the growth of the chronic cough market.

What Are The Major Segments Identified In The Chronic Cough Market?

The chronic coughmarket covered in this report is segmented –

1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Combination Drug; Antibiotics; Acid Blockers; Other Drug Classes

2) By Route Of Administration: Oral; Inhalational; Injectable; Other Route Of Administrations

3) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

Subsegments:

1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines

2) By Corticosteroids: Inhaled Corticosteroids; Systemic Corticosteroids

3) By Decongestants: Oral Decongestants; Nasal Decongestants

4) By Combination Drug: Antihistamine And Decongestant Combinations; Cough Suppressant And Expectorant Combinations

5) By Antibiotics: Macrolides; Penicillins; Cephalosporins

6) By Acid Blockers: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists

7) By Other Drug Classes: Mucolytics; Cough Suppressants; Herbal Remedies

What Trends Are Expected To Drive The Chronic Cough Market?

Leading companies in the chronic cough market are focused on developing innovative products, such as biosimilars, to strengthen their standing in the sector. These biosimilars are utilized for treating conditions like cancer, autoimmune diseases, and diabetes, offering economical alternatives to existing biologics. For instance, in July 2024, Sandoz, a Switzerland-based Pharmaceutical company, introduced its biosimilar Pyzchiva (ustekinumab) across Europe. This product targets chronic inflammatory diseases, including plaque psoriasis, psoriatic arthritis, and Crohn’s disease. This biosimilar is especially noteworthy as it represents the first of its kind available in Europe with all reference medicine strengths, including the initial dose for Crohn’s disease. Developed through a collaboration with Samsung Bioepis, Sandoz aims to broaden access to effective treatments for millions impacted by these conditions. The launch highlights Sandoz’s commitment to delivering affordable healthcare solutions and enhancing the quality of life for patients throughout Europe.

Which Major Firms Are Strengthening Their Position In The Chronic Cough Industry?

Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Chronic Cough Market?

North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Cough Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12109&type=smp

Browse Through More Reports Similar to the Global Chronic Cough Market 2025, By The Business Research Company

Oil And Gas Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oil-and-gas-global-market-report

Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Oil And Gas Upstream Activities Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oil-and-gas-upstream-activities-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795